🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “China” Clear

  1. Desflurane

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Delirium

    small molecule active

    1 trial

  2. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cardiac Surgery

    small molecule completed

    1 trial

  3. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchoscopy

    small molecule active

    1 trial

  4. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    small molecule completed

    1 trial

  5. Dexmedetomidine Injection (nasal spray) + Propofol Injection + Sufentanil Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Dexmedetomidine Induced Sedation

    small molecule completed

    1 trial

  6. Dexmedetomidine group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colonoscopy

    small molecule completed

    1 trial

  7. Dexmedetomidine supplemented morphine analgesia

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Elderly

    small molecule completed

    1 trial

  8. Diclofenac

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    small molecule completed

    1 trial

  9. Dobutamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Patients With Septic Shock

    small molecule completed

    1 trial

  10. Drug treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prolactinoma

    small molecule active

    1 trial

  11. ET-01

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Transfusion Dependent Beta-Thalassaemia

    mab completed

    1 trial

  12. EVM18001 Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    System Lupus Erythematosus(SLE)

    mab active

    1 trial

  13. Early Nutrition Intervention

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nutrition

    other completed

    1 trial

  14. Enteral immunonutrition

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Locally Advanced Nasopharyngeal Carcinoma

    other active

    1 trial

  15. Escitalopram

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Major Depressive Disorder (MDD)

    small molecule active

    1 trial

  16. Escitalopram (Oral antidepressant)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depression - Major Depressive Disorder

    small molecule active

    1 trial

  17. Esketamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anesthesia

    small molecule active

    1 trial

  18. Esketamine-lidocaine group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Chronic Pain

    small molecule active

    1 trial

  19. Etomidate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Complications

    small molecule completed

    1 trial

  20. Exclusive Enteral Nutrition Therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Crohn's Disease

    other completed

    1 trial

  21. FAST Technique

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ST-Segment Elevation Myocardial Infarction

    other active

    1 trial

  22. FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Biliary Tract Neoplasms

    small molecule active

    1 trial

  23. Fecal Microbiota Transplantation (FMT)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 1 Diabetes

    mab active

    1 trial

  24. Fosinopril

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetes Mellitus

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources